Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: A factorial study

Journal of Clinical Oncology

Volumn 22, Issue 13, 2004, Pages 2643-2653

  Kwong, Dora L W ^a   Sham, Jonathan S T ^a   Au, Gordon K H ^a   Chua, Daniel T T ^a   Kwong, Philip W K ^a   Cheng, Ashley C K ^a   Wu, P M ^a   Law, Martin W M ^a   Kwok, Carol C H ^a   Yau, C C ^a   Wan, K Y ^a   Chan, Raymond T T ^a   Choy, Damon D K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; TEGAFUR; URACIL; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FACTORIAL ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADULT; AGED; CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; ORAL DRUG ADMINISTRATION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHOTREXATE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; TEGAFUR; TREATMENT OUTCOME; URACIL; VINCRISTINE;

EID: 4344709667     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.05.173     Document Type: Article

References (29)

1. Teo P, Yu P, Lee WY, et al: Significant prognosticators after primary radiotherapy in non-disseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36:291-304, 1996
2. Geara FB, Sanguineti G, Tucker SL, et al: Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival. Radiother Oncol 43:53-61, 1997
3. Sanguineti G, Geara F, Garden A, et al: Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control. Int J Radiat Oncol Biol Phys 37:985-996, 1997
4. Heng DM, Wee J, Fong KW, et al: Prognostic factors in 677 patients in Singapore with non-disseminated nasopharyngeal carcinoma. Cancer 86:1912-1920, 1999
5. Huncharek M, Kupelnick B: Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: Results of a metaanalysis of 1,528 patients from six randomized trials. Am J Clin Oncol 25:219-223, 2002
6. Al-Sarraf M, Leblanc M, Giri S, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol 16:1310-1317, 1998
7. Al-Sarraf M, McLaughlin P: Nasopharyngeal carcinoma: Choice of treatment. Int J Radiat Oncol Biol Phys 33:761-763, 1995
8. Ho JHC: Stage classification of nasopharyngeal carcinoma, in de Tha G, Ito Y (eds): Nasopharyngeal Carcinoma: Etiology and Control. Lyon, France, IARC Scientific Publications, 1978, pp 99-113
9. Taguchi T: Clinical application of biochemical modulation in cancer chemotherapy: Biochemical modulation for 5FU. Oncology 54:12-18, 1997 (suppl 1)
10. Byfield JE: 5-fluorouracil radiation sensitization: A brief review. Invest New Drugs 7:111-116, 1989
11. Yamakawa M, Niibe H, Honjo J, et al: Experimental studies on the combined effect of radiation and UFT 2: Fractionated treatments combining UFT and X ray radiation. Gan To Kagaku Ryoho 17:1173-1179, 1990
12. Minsky BD: UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: A comprehensive review. Int J Cancer 96:1-10, 2001
13. SECOG Participants: A randomised trial of combined multi-drug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 12:289-295, 1986
14. Merlano M, Rosso R, Sertoli MR, et al: Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: A phase III study. J Clin Oncol 6:627-632, 1988
15. Amichetti M, Valentini A: Comparative study of two neoadjuvant protocols (VBM and DDP-BLM) combined with radiation therapy in advanced head and neck cancer. J Chemother 1:68-71, 1989
16. Clavel M, Cognetti F, Dodion P, et al: Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck. Cancer 60:1173-1177, 1987
17. Allison PD: Survival analysis using the SAS system: A practical guide. Cary, NC, SAS Institute Inc, 1995, pp 111-184
18. American Joint Committee on Cancer: AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven Publishers, 1997, pp 33-38
19. Lee AW, Foo W, Law SC, et al: Staging of nasopharyngeal carcinoma: From Ho's to the new UICC system. Int J Cancer 84:179-187, 1999
20. Lee AW, Foo W, Law CK, et al: N-staging of nasopharyngeal carcinoma: Discrepancy between UICC/AJCC and Ho systems - Union Internationale Contre le Cancer/American Joint Committee for Cancer. Clin Oncol (R Coll Radiol) 8:155-159, 1996
21. Lam P, Yuen AP, Ho CM, et al: Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma. Eur J Surg Oncol 27:750-753, 2001
22. Tanaka F, Miyahara R, Ohtake Y, et al: Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 14:256-262, 1998
23. Fujii M: Comparative clinical studies for head and neck cancer in Japan. Gan To Kagaku Ryoho 29:1502-1508, 2002
24. Lin JC, Jan JS, Hsu CY, et al: Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 21:631-637, 2003
25. Chan ATC, Teo PML, Ngan RK, et al: Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in loco-regionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20:2038-2044, 2002
26. Rossi A, Molinari R, Boracchi P, et al: Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study. J Clin Oncol 6:1401-1410, 1988
27. Chi KH, Chang YC, Guo WY, et al: A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52:1238-1244, 2002
28. Peters LJ, Harrison ML, Dimery IW, et al: Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 14:623-633, 1988
29. Bloss JD, DiSaia PJ, Mannel RS, et al: Radiation myelitis: A complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix. Gynecol Oncol 43:305-308, 1991